• Linkedin
  • Twitter
  • Pinterest
  • Vimeo
  • Skype
  • Gplus
  • Youtube
  • Rss
  • Home
  • Events
  • Careers at CAPTIS
  • Log In / Sign In ▼
    • Log In with LinkedIn
    • Register w/out LinkedIn
    • Login w/out LinkedIn
    • Reset Lost Password
  • 🔒 MEMBER AREA ▼
    • View your profile
    • Edit your profile
    • Log out
       ☎ US Offices 1 (800) 445-1839 Toll Free | Europe/Int'l +41 22 518 2100
CAPTIS Executive Search
  • Home
  • You are a Business
    • Executive Search
    • Our Commitments
    • Other Services
    • Our Locations
    • About Us
    • Key Values
  • You are a Healthcare Executive
    • Dealing with CAPTIS
    • Candidate Contact Form
    • Login with LinkedIn
    • Create an Account
    • Log in (Existing Account)
    • WW Trade Shows
      • Medical & Pharmaceutical
      • Orthopedics
      • Spine
      • Cardiovascular
      • Diagnostics
      • Wound Care
      • Plastic & Aesthetic Surgery
      • Surgery
      • Trauma
      • Pediatric Care
    • Industry News
      • News
      • Wall Street Beat
      • Business/Financial News
      • Clinical Trials
      • Musculoskeletal News Roundup
      • Cardiovascular
      • M&A Activity
      • Food & Drug Administration (FDA)
      • Wound Care
      • Practice Management
  • CAPTIS Magazine
    • Healthcare News
    • @CaptisCorp Twitter Timeline
    • Healthcare Events
    • CAPTIS LinkedIn Timeline
    • Articles ➜
      • Recruiting
      • Personal Development
      • News
  • Make an Inquiry
  • Contact Us
    • General Contact Form
    • Healthcare Executive Contact
    • Apply for a position at CAPTIS
    • Call 1 800 445 1839
      (Cell/Mobile US & Canada Toll Free, or Skype)
    • Call +41 22 518 2100
      (Cell/Mobile Swiss Landline Switchboard, or Skype)
  • Search
  • Menu

Captare. Aestimare. Eligere. Succedere.

CAPTIS – Your Global Healthcare & MedTech Executive Search Provider

You are a Business

You are an Executive

Want to work at CAPTIS

Learn about our services

 

 

Executive Search
Submit an inquiry

GET HEADHUNTED!

Create and/or update

your confidential profile

 

Healthcare Executive General Information
Create an account & Add your profile

Go to our Careers page

 

 

 

 

 

CAPTIS Careers

Recent Healthcare News:

12/13/2018/by CAPTIS

ConMed to acquire Buffalo Filter for $365m

ConMed (NSDQ:CNMD) said today that it inked a deal to acquire…
12/13/2018/by CAPTIS

FDA: GE R860 ventilator safety guard recall is Class I

12/13/2018/by CAPTIS

Edwards to add 370 employees in Costa Rica

12/13/2018/by CAPTIS

Acute decompensated HF treatment device dev WhiteSwell raises $30m in Series B

12/13/2018/by CAPTIS

Check-Cap wins conditional IDE approval for C-Scan pilot study

12/13/2018/by CAPTIS

Report: Apple hiring dozens of MDs, solidifies venture into healthcare

12/13/2018/by CAPTIS

Hologic touts win in trade secret case

12/13/2018/by CAPTIS

Bovie to rebrand as Apyx Medical, move to NASDAQ

12/13/2018/by CAPTIS

Report: J&J willing to pay more than $400m to settle Pinnacle hip cases

12/13/2018/by CAPTIS

X-Chem, Almirall forge dermatology-focused drug discovery alliance

12/13/2018/by CAPTIS

Weizmann researchers discover new neural mechanism underlying anxiety

Targeting this biochemical pathway may help develop new therapies…
12/13/2018/by CAPTIS

Ra Pharma’s zilucoplan meets primary endpoints in phase 2 gMG trial

12/13/2018/by CAPTIS

Janssen’s Tremfya meets primary endpoint in phase 3 psoriasis trial

12/12/2018/by CAPTIS

UK preparing for ‘worst-case’ medical supply Brexit plan

12/12/2018/by CAPTIS

Sanuwave confirms acting CEO Richardson as company head | Personnel Moves – December 12, 2018

12/12/2018/by CAPTIS

Appeals court OKs $248m Stryker win over Zimmer Biomet

12/12/2018/by CAPTIS

Schrödinger, TB Alliance collaborate to advance tuberculosis drug discovery

12/12/2018/by CAPTIS

Versant Ventures launches new biotech firm Black Diamond Therapeutics

12/11/2018/by CAPTIS

Circassia to acquire full US rights of AstraZeneca’s COPD treatment Tudorza

12/11/2018/by CAPTIS

Boston Scientific touts win in continued TAVR patent spat with Edwards Lifesciences

Go to the Healthcare News

Recent news from your industry: Finance, M&A, Products, Companies and more…

Upcoming Events:

We Suggest:

Seisa Medical, CA attorney settle alleged $2m fraud suit

0 Comments
/
12/11/2018
Seisa Medical has settled a case against an allegedly fraudulent…
Read more
https://www.captis.com/wp-content/uploads/2018/12/saisa-medical-large-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 13:43:362018-12-11 15:01:44Seisa Medical, CA attorney settle alleged $2m fraud suit

Strata Skin Sciences adds license for excimer laser vitiligo treatment 

0 Comments
/
12/11/2018
Strata Skin Sciences (NSDQ:SSKN) said it has reached an agreement…
Read more
https://www.captis.com/wp-content/uploads/2018/12/Strata-Skin-Sciences-300x195.jpg 195 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 11:01:532018-12-11 12:31:59Strata Skin Sciences adds license for excimer laser vitiligo treatment 

Seno Medical Instruments touts Imagio breast cancer subtype ID trial results

0 Comments
/
12/11/2018
Seno Medical Instruments today released results from a study…
Read more
https://www.captis.com/wp-content/uploads/2018/12/seno-medical-large-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 10:57:472018-12-11 12:01:18Seno Medical Instruments touts Imagio breast cancer subtype ID trial results

LumiThera inks Italian Valeda distro deal

0 Comments
/
12/11/2018
LumiThera said today that it inked a deal with ophthalmology…
Read more
https://www.captis.com/wp-content/uploads/2018/12/lumithera-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 10:33:162018-12-11 12:01:15LumiThera inks Italian Valeda distro deal

BioCardia submits bid for FDA clearance of Avance transseptal introducer

0 Comments
/
12/11/2018
BioCardia (NSDQ:BCDA) said today that it submitted an application…
Read more
https://www.captis.com/wp-content/uploads/2018/12/biocardia-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 10:17:322018-12-11 11:31:14BioCardia submits bid for FDA clearance of Avance transseptal introducer

Report: India still lacks solid medical device regulation

0 Comments
/
12/11/2018
It has been 13 years since Indian health authorities were directed…
Read more
https://www.captis.com/wp-content/uploads/2018/12/india-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 09:51:232018-12-11 11:01:27Report: India still lacks solid medical device regulation

In2Bones intros ‘see-through’ implant for flat feet

0 Comments
/
12/11/2018
(Image courtesy of In2Bones) Orthopedic surgical device developer…
Read more
https://www.captis.com/wp-content/uploads/2018/12/In2BonesPitStop-300x195.jpg 195 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 08:50:322018-12-11 10:01:51In2Bones intros ‘see-through’ implant for flat feet

NuVasive wins expanded FDA nod for Monolith corpectomy system

0 Comments
/
12/11/2018
NuVasive (NSDQ:NUVA) said yesterday that it won expanded…
Read more
https://www.captis.com/wp-content/uploads/2018/12/nuvasive-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 08:37:062018-12-11 10:01:49NuVasive wins expanded FDA nod for Monolith corpectomy system

Enhancing post-market safety

0 Comments
/
12/11/2018
Ashton Steinhagen, lead clinical research associate for IMARC…
Read more
https://www.captis.com/wp-content/uploads/2018/12/IMARC-logo-new-300x195.png 195 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 07:47:532018-12-11 09:02:04Enhancing post-market safety

Feds drop insider trading, perjury charges against ex-AMO chief Mazzo

0 Comments
/
12/11/2018
Federal prosecutors this week dropped perjury and insider trading…
Read more
https://www.captis.com/wp-content/uploads/2018/12/gavel-legal-multiuse-150x97-1.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 07:42:212018-12-11 09:02:02Feds drop insider trading, perjury charges against ex-AMO chief Mazzo

Olympus fined $85 million in duodenoscope case; former exec faces prison

0 Comments
/
12/11/2018
(Photo by rawpixel on Unsplash) Olympus (TYO:7733) and a…
Read more
https://www.captis.com/wp-content/uploads/2018/12/gavel-150x97.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 07:38:312018-12-11 09:02:00Olympus fined $85 million in duodenoscope case; former exec faces prison

Cardinal Health launches supply chain solution

0 Comments
/
12/11/2018
Cardinal Health has launched a supply chain automation solution…
Read more
https://www.captis.com/wp-content/uploads/2018/12/cardinal-health-logo-300x195.png 195 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 07:33:112018-12-11 09:01:57Cardinal Health launches supply chain solution

Shareholders approve Avista, Organogensis tie up

0 Comments
/
12/11/2018
Private equity firm Avista Healthcare Public Acquisition Corp.…
Read more
https://www.captis.com/wp-content/uploads/2018/12/avista-organogensis-small-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 07:03:172018-12-11 08:31:37Shareholders approve Avista, Organogensis tie up

Tela Bio raises more than $2 million

0 Comments
/
12/11/2018
Regenerative surgical implants company Tela Bio has brought in…
Read more
https://www.captis.com/wp-content/uploads/2018/12/tela-bio-7x4-300x171.jpg 171 300 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 07:03:002018-12-11 08:31:34Tela Bio raises more than $2 million

Abiomed puts $15m into Shockwave

0 Comments
/
12/11/2018
Abiomed (NSDQ:ABMD) plans to invest $15 million in Shockwave…
Read more
https://www.captis.com/wp-content/uploads/2018/12/shockwave-lithotripsy-cath-7x4-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 06:46:532018-12-11 08:02:36Abiomed puts $15m into Shockwave

FDA advisory panel to mull transvaginal mesh

0 Comments
/
12/11/2018
The FDA plans to hold an advisory committee meeting in February…
Read more
https://www.captis.com/wp-content/uploads/2018/12/fda-large-150x97-1.jpg 97 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 06:32:252018-12-11 08:02:34FDA advisory panel to mull transvaginal mesh

House tax bill would delay medical device tax by another 5 years

0 Comments
/
12/11/2018
A bill to extend this year’s tax cuts would also put a…
Read more
https://www.captis.com/wp-content/uploads/2018/12/medical-device-tax-7x4-150x86.jpg 86 150 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 06:22:292018-12-11 07:31:17House tax bill would delay medical device tax by another 5 years

Alnylam, Silence Therapeutics settle patent dispute

0 Comments
/
12/11/2018
The agreement allows both firms to resolve all litigation across…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 02:31:372018-12-11 03:31:39Alnylam, Silence Therapeutics settle patent dispute

e-therapeutics, Novo Nordisk enter into research collaboration agreement

0 Comments
/
12/11/2018
Type 2 diabetes currently accounts for approximately 90% of the…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-11 01:32:142018-12-11 02:32:15e-therapeutics, Novo Nordisk enter into research collaboration agreement

PCI expands cold chain storage capabilities at UK site

0 Comments
/
12/10/2018
The announcement is the latest in a series of strategic investments…
Read more
https://www.captis.com/wp-content/uploads/2017/02/004.jpg 450 900 CAPTIS https://www.captis.com/wp-content/uploads/2016/11/logo_transp_top_final.png CAPTIS2018-12-10 23:31:062018-12-11 00:31:08PCI expands cold chain storage capabilities at UK site
PreviousNext

  • Thorough Network

  • Deep Knowledge

  • Comprehensive Process

  • Ethical Approach

  • Confidentiality

  • Assessment Capacity

99%

Percentage of successful project completion

85%

Of placed executives remain with the client company 3 or more years

  • Share on Facebook
  • Share on Twitter
  • Share on Google+
  • Share on Pinterest
  • Share on Linkedin
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail

News from Twitter

Twitter
Novartis Cancer
Novartis Cancer
@NovartisCancer

Cancer is not a ‘one size fits all,’ nor is the way we treat it. We are working to better understand the different ways a cancer can mutate so we can discover new approaches to treat some of the most difficult-to-treat types of the disease. #ReimagineMedicine #ESMO18 pic.twitter.com/41QL…

reply retweet favorite
6:56 pm · 10/24/2018 ·
Retweeted by CAPTIS
Twitter
Epic CV
Epic CV
@Epic_CV

Read carefully employer's directions on how to apply. #resume #resumetips

reply retweet favorite
7:47 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
World Spine Care
World Spine Care
@WorldSpineCare

Here are 5 Tips to Avoid Back Pain from #WorldSpineDay. #Exercise #Posture #Stress #HealthyEating #Strength pic.twitter.com/AT1D…

reply retweet favorite
7:46 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Neurochecklists
Neurochecklists
@neurochecklists

Large-vessel giant cell arteritis: diagnosis, monitoring and management | Rheumatology | Oxford Academic academic.oup.com/rhe…

reply retweet favorite
7:40 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Stryker Endoscopy
Stryker Endoscopy
@StrykerEndo

Scientists have made an unexpected discovery while investigating the triggering factors of #ColonCancer: Cell stress in combination with an altered microbiota in the colon drives tumor growth. Learn more: ow.ly/JxtK30meLTY pic.twitter.com/U51Q…

reply retweet favorite
7:39 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
Implantech
Implantech
@Implantech

If you are in Dallas attending the AAFPRS 12th International Symposium of Facial Plastic Surgery don’t miss out on this Breakfast Symposium tomorrow morning with Dr. William Binder that is sponsored by Implantech! #implantech #superiorpatientaesthetics #implantechrewards #aafprs pic.twitter.com/HCzK…

reply retweet favorite
7:38 am · 10/16/2018 ·
Retweeted by CAPTIS
Twitter
American College of Cardiology
American College of Cardiology
@ACCinTouch

Less than one month left to submit your science for #ACC19! Abstract & case submissions are due Oct. 16. Learn more: ow.ly/4nyf30lYZxh pic.twitter.com/Mnwv…

reply retweet favorite
4:46 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Novartis Cancer
Novartis Cancer
@NovartisCancer

With #CARTcell therapy, an inactive virus programs T cells with new genetic information to help recognize specific antigens found on normal cells and certain blood cancer cells. As the CAR-T cells multiply, new copies also gain this ability. #CARTCellStory pic.twitter.com/Xuoh…

reply retweet favorite
4:42 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Integra LifeSciences
Integra LifeSciences
@integra_life

Make plans to visit the Integra LifeSciences Booth# 919 during Plastic Surgery The Meeting September 28th - October 1st. #Integra_LifeSciences #DurableIsBeautiful #PSTM18 #ASPS #PlasticSurgery pic.twitter.com/8QGv…

reply retweet favorite
4:42 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
Fundamental Surgery
Fundamental Surgery
@FundamentalSurg

We are live at #NASS2018 stand 2649. Get hands-on with the world's leading surgical #simulator in #VR with #haptics and experience the future of surgical training. #wearefundamental fundamentalsurgery.c… pic.twitter.com/NgzA…

reply retweet favorite
4:41 pm · 09/26/2018 ·
Retweeted by CAPTIS
Twitter
K2M, Inc. Jobs
K2M, Inc. Jobs
@K2MIncJobs

Congratulations to Lane Major for his recent promotion to Chief Operating Officer @K2MInc! Read more: bit.ly/LaneMajor pic.twitter.com/iDXk…

reply retweet favorite
12:45 pm · 03/31/2018 ·
Retweeted by CAPTIS
Twitter
TRX Orthopedics
TRX Orthopedics
@TRXOrtho

Great things happening at Tissue Regenix! Plan to visit our booth at the AAOS meeting in New Orleans, under the CellRight Technologies banner #5413. @AAOS1

reply retweet favorite
8:34 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Corin Group
Corin Group
@corintechnology

All evaluation cases for the new Corin Dual Mobility option for the Trinity Acetabular cup system have now been completed and we're looking forward to the full launch. Click lnkd.in/g8ariEY for details #orthopaedics #technology #totalhip #uniquehip pic.twitter.com/SPsy…

reply retweet favorite
8:33 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Omar Ishrak
Omar Ishrak
@MedtronicCEO

Thank you to our @Medtronic employees around the globe! Q3 saw strong, balanced results, with diversified performance in all groups and regions. #MDTEarnings

reply retweet favorite
8:33 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Cardiovascular News
Cardiovascular News
@Cardiovasc_bio

#cardiovascular news CorFlow Presents Fundamental New Insights into the Coronary Microcirculation at ACC - CorFlow Therapeutics AG corflowtherapeutics.… today announced that the company will present fundamental new insights into the coronary microci... ow.ly/OlaG50gAElO

reply retweet favorite
8:32 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
Integra LifeSciences
Integra LifeSciences
@integra_life

Welcome Sravan Emany, our new vice president, treasurer and head of investor relations. investor.integralife… pic.twitter.com/wzt5…

reply retweet favorite
8:31 pm · 03/02/2018 ·
Retweeted by CAPTIS
Twitter
José Luis Maçãs
José Luis Maçãs
@zeluismacas

Read in this edition all about Novartis Oncology’s ground-breaking CAR-T therapy; how SwissMedic is leading the world in terms of regulatory innovation; the story of Actelion’s acquisition by J&J and the subsequent emergence of a new entity – Idorsia. pharmaboardroom.com/…

reply retweet favorite
11:29 am · 02/10/2018 ·
Retweeted by CAPTIS
Twitter
SOFCOT
SOFCOT
@sofcot_ortho

Thème du congrès SOFCOT 2018 : "La Décision Médicale" pic.twitter.com/hJT5…

reply retweet favorite
11:25 am · 02/10/2018 ·
Retweeted by CAPTIS
Twitter
EUROSPINE
EUROSPINE
@EUROSPINESoc

Exactly 3 weeks left to submit your abstract for #EUROSPINE2018 - #deadline 1 March 2018 #research #spine #SpineResearch #spineSurgery #SpinalDisorder #ScientificPaper #BasicScience #ClinicalResearch #PublishResearch @EurSpineJournal buff.ly/2ExMQ7e pic.twitter.com/Fx2Q…

reply retweet favorite
11:25 am · 02/10/2018 ·
Retweeted by CAPTIS
Twitter
Olea Medical
Olea Medical
@OleaMedical

Throughout the week, we are in #Bruges alongside Prof. Jan Casselman for an #Erasmus course program on #ENT imaging, held at the Oud Sint-Jan congress centre. The training of around 170 radiologists is based on images from our post-processing solution Olea Sphere®V3.0. #MRI pic.twitter.com/KSUU…

reply retweet favorite
11:24 am · 02/10/2018 ·
Retweeted by CAPTIS
Follow @CaptisCorp

Follow CAPTIS



CAPTIS
Followon TwitterSubscribeto RSS Feed

We Recommend

Our very best and up-to-date selection of healthcare Industries' News (Products, Markets, Companies, R&D, Technology, Opportunities, Investment & Finance...).
Read at Healthcare News

CAPTIS Newsletter

Call CAPTIS

United States Offices
1 (800) 445-1839

(United States & Canada Toll Free)

Europe & International
+41 22 518 2100

© CAPTIS - Executive Search - 2017 - copyright@captis.com
  • Linkedin
  • Twitter
  • Pinterest
  • Vimeo
  • Skype
  • Gplus
  • Youtube
  • Rss
  • Events
  • For Healthcare Executives
  • Legal & Privacy Notes, GDPR & Cookies Policy
  • Client Area
X
Thank you for visiting our new website! Help us improve, let us know your feedback (Anonymous 2 min survey)
Survey
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OK, got itCookies Policy
Scroll to top